Literature DB >> 16721066

A novel guanine nucleotide exchange factor MyoGEF is required for cytokinesis.

Di Wu1, Michael Asiedu, Robert S Adelstein, Qize Wei.   

Abstract

The cleavage furrow is created by an actomyosin contractile ring that is regulated by small GTPase proteins such as Rac1 and RhoA. Guanine nucleotide exchange factors (GEFs) are positive regulators of the small GTPase proteins and have been implicated as important factors in regulating cytokinesis. However, it is still unclear how GEFs regulate the contractile ring during cytokinesis in mammalian cells. Here we report that a novel GEF, which is termed MyoGEF (myosin-interacting GEF), interacts with non-muscle myosin II and exhibits activity toward RhoA. MyoGEF and non-muscle myosin II colocalize to the cleavage furrow in early anaphase cells. Disruption of MyoGEF expression in U2OS cells by RNA interference (RNAi) results in the formation of multinucleated cells. These results suggest that MyoGEF, RhoA, and non-muscle myosin II act as a functional unit at the cleavage furrow to advance furrow ingression during cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721066      PMCID: PMC2034313          DOI: 10.4161/cc.5.11.2815

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

1.  Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases.

Authors:  V Benard; B P Bohl; G M Bokoch
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.

Authors:  Jianjun Bao; Siddhartha S Jana; Robert S Adelstein
Journal:  J Biol Chem       Date:  2005-03-17       Impact factor: 5.157

Review 3.  Cleavage furrow formation and ingression during animal cytokinesis: a microtubule legacy.

Authors:  Pier Paolo D'Avino; Matthew S Savoian; David M Glover
Journal:  J Cell Sci       Date:  2005-04-15       Impact factor: 5.285

4.  Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho.

Authors:  T Matsui; M Amano; T Yamamoto; K Chihara; M Nakafuku; M Ito; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

Review 5.  Rho GTPases.

Authors:  D J Mackay; A Hall
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

6.  Cloning of the cDNA encoding human nonmuscle myosin heavy chain-B and analysis of human tissues with isoform-specific antibodies.

Authors:  C L Phillips; K Yamakawa; R S Adelstein
Journal:  J Muscle Res Cell Motil       Date:  1995-08       Impact factor: 2.698

7.  Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors:  K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

8.  The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts.

Authors:  R Kozma; S Ahmed; A Best; L Lim
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

9.  Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton.

Authors:  X D Ren; W B Kiosses; M A Schwartz
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Expression of light meromyosin in Dictyostelium blocks normal myosin II function.

Authors:  C G Burns; M Reedy; J Heuser; A De Lozanne
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

View more
  25 in total

Review 1.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.

Authors:  Michelle C Helms; Elda Grabocka; Matthew K Martz; Christopher C Fischer; Nobuchika Suzuki; Philip B Wedegaertner
Journal:  Cell Signal       Date:  2015-10-19       Impact factor: 4.315

3.  Novel functions of Ect2 in polar lamellipodia formation and polarity maintenance during "contractile ring-independent" cytokinesis in adherent cells.

Authors:  Masamitsu Kanada; Akira Nagasaki; Taro Q P Uyeda
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

4.  GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.

Authors:  Jörg Birkenfeld; Perihan Nalbant; Benjamin P Bohl; Olivier Pertz; Klaus M Hahn; Gary M Bokoch
Journal:  Dev Cell       Date:  2007-05       Impact factor: 12.270

Review 5.  Rho GTPases as regulators of mitosis and cytokinesis in mammalian cells.

Authors:  Megan Chircop
Journal:  Small GTPases       Date:  2014-07-02

6.  Myosin II is a negative regulator of oligodendrocyte morphological differentiation.

Authors:  Haibo Wang; Tomasz Rusielewicz; Ambika Tewari; Ellen M Leitman; Steven Einheber; Carmen V Melendez-Vasquez
Journal:  J Neurosci Res       Date:  2012-03-21       Impact factor: 4.164

Review 7.  Myosin phosphatase target subunit: Many roles in cell function.

Authors:  Fumio Matsumura; David J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

8.  Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.

Authors:  D Wu; M Asiedu; Q Wei
Journal:  Oncogene       Date:  2009-06-04       Impact factor: 9.867

9.  Phosphorylation of MyoGEF on Thr-574 by Plk1 promotes MyoGEF localization to the central spindle.

Authors:  Michael Asiedu; Di Wu; Fumio Matsumura; Qize Wei
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

Review 10.  Rho GTPases in animal cell cytokinesis: an occupation by the one percent.

Authors:  Shawn N Jordan; Julie C Canman
Journal:  Cytoskeleton (Hoboken)       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.